Early vitamin B12 treatment mitigates hippocampal neuroinflammation and preserves NeuN-expressing neuron density in a hamster model of post-acute COVID-19

For many people who recover from a mild case of COVID-19, the virus seems to vanish, but the body does not always return to normal. A lingering condition known as long COVID can leave patients with persistent brain fog, memory lapses, and difficulty concentrating. Scientists have long suspected that this cognitive decline is not just a feeling but a physical change in the brain, specifically in a region called the hippocampus. This area is the brain's command center for memory and learning. When the immune system stays active too long after an infection, it can cause a low-level fire, or inflammation, within the brain. This inflammation can damage the delicate connections between nerve cells and even cause the cells themselves to die. One specific chemical signal, a protein called CCL11, has been identified as a key player in this process. In high amounts, CCL11 acts like a distress beacon that recruits immune cells to the brain, where they can inadvertently harm healthy neurons and disrupt the ability to form new memories.

Researchers have been searching for safe, accessible ways to calm this internal fire and protect the brain. One promising candidate is vitamin B12, a common nutrient found in meat and dairy. Beyond its role in keeping blood and nerves healthy, B12 acts as a molecular switch in the body, helping to turn certain genes on or off. Previous work suggested that B12 could potentially silence the genes that produce the harmful CCL11 signal. To test if this simple vitamin could stop the brain damage associated with long COVID, a team of scientists turned to a model that closely mimics the human experience: the golden Syrian hamster. These small animals are highly susceptible to the SARS-CoV-2 virus, the pathogen that causes COVID-19, and they develop symptoms similar to mild cases in humans, including weight loss and changes in behavior. By studying these animals, the researchers could observe what happens inside the brain during the weeks following the initial infection and see if early treatment with vitamin B12 could change the outcome.

The team began by infecting a group of hamsters with the Omicron variant of the virus, a strain that caused the global pandemic. They divided the animals into groups, with some receiving a placebo and others receiving vitamin B12 injections starting just three days after the infection began. The researchers monitored the animals closely, tracking their weight and how much they ate, before eventually examining their brains fifteen days after the infection. This timeframe was chosen to represent the post-acute phase, the period when the virus is no longer the main threat, but the body is still dealing with the aftermath. The scientists then looked at the hippocampus, the memory center of the brain, using powerful microscopes and genetic sequencing tools to count cells, measure chemical levels, and read the instructions inside the cells that tell them how to behave.

The results showed that the virus had indeed left a mark on the brain. The infected hamsters, particularly the females, showed a significant rise in the levels of CCL11 within their hippocampus. This surge was accompanied by an increase in the number of immune cells, known as microglia, which had changed their shape to become more aggressive and less branched, a sign that they were in a state of high alert. This inflammatory environment took a toll on the brain's architecture. The density of healthy, mature neurons in the hippocampus dropped, meaning the brain had lost some of its essential building blocks. The study also revealed that the brain's reaction was not the same for every animal; female hamsters showed a more dramatic shift in their genetic activity, turning on pathways associated with cell death and energy stress, while males showed a different, though still altered, pattern.

However, the hamsters that received vitamin B12 fared much better. The treatment did not completely stop the weight loss that comes with the acute phase of the illness, but it did prevent the animals from losing their appetite, a crucial sign of recovery. More importantly, the vitamin acted as a shield for the brain. In the treated animals, the levels of the harmful CCL11 chemical did not spike as high as they did in the untreated group. The immune cells remained calmer, retaining their complex, branched shapes rather than becoming aggressive. Most significantly, the treatment preserved the density of neurons in the hippocampus. The brain cells that are responsible for memory were saved from the decline seen in the untreated animals. The researchers found that the vitamin worked by subtly changing how genes were read, effectively dampening the signals that lead to inflammation and cell loss, while helping to maintain the brain's normal structure.

The study also highlighted that biology is not one-size-fits-all. The effects of the virus and the vitamin varied between male and female hamsters and even between different tiny sections of the hippocampus. In females, the vitamin successfully blocked the genetic pathways that lead to neurodegeneration, or the breakdown of nerve cells. In males, the response was more complex, with the vitamin activating some energy pathways that were not active in the untreated group. This suggests that the brain's reaction to infection and its recovery are deeply influenced by sex, a factor that must be considered in future treatments. The researchers did not find evidence that the virus itself was still actively replicating in the brain at this stage, pointing instead to the lingering immune response as the primary cause of the damage.

This work provides a clear picture of how a viral infection can trigger a chain reaction in the brain that leads to lasting cognitive issues, and it offers a potential way to interrupt that chain. The findings suggest that vitamin B12, a safe and inexpensive nutrient, could serve as an early intervention to protect the brain from the inflammatory fallout of COVID-19. By keeping the immune system in check and preserving the density of neurons, the vitamin may help prevent the transition from a temporary infection to a chronic state of brain fog. While the study was conducted in hamsters, the biological mechanisms involved are shared with humans, offering a strong rationale for further investigation. The research underscores that the path to recovery from a viral illness may involve more than just waiting for the fever to break; it may require active steps to calm the brain's immune system before the damage becomes permanent.